{"id":1067925,"date":"2021-02-06T08:51:10","date_gmt":"2021-02-06T13:51:10","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/igm-biosciences-to-present-at-the-guggenheim-healthcare-talks-2021-idea-forum-oncology-day\/"},"modified":"2024-08-18T11:40:59","modified_gmt":"2024-08-18T15:40:59","slug":"igm-biosciences-to-present-at-the-guggenheim-healthcare-talks-2021-idea-forum-oncology-day","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/igm-biosciences-to-present-at-the-guggenheim-healthcare-talks-2021-idea-forum-oncology-day.php","title":{"rendered":"IGM Biosciences to Present at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day"},"content":{"rendered":"<p><![CDATA[MOUNTAIN VIEW, Calif., Feb.  05, 2021  (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day on February 12, 2021 at 2:00 p.m. ET. The conference will be held in a virtual meeting format.]]><\/p>\n<p>Read more:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2021\/02\/05\/2170616\/0\/en\/IGM-Biosciences-to-Present-at-the-Guggenheim-Healthcare-Talks-2021-Idea-Forum-Oncology-Day.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"IGM Biosciences to Present at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day\">IGM Biosciences to Present at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read more: IGM Biosciences to Present at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/igm-biosciences-to-present-at-the-guggenheim-healthcare-talks-2021-idea-forum-oncology-day.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1067925","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067925"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1067925"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067925\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1067925"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1067925"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1067925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}